Nisaurrahmah N, Sri O, Ifora I. Efficacy and Safety of 5-Hydroxytryptamine-3 Receptor Antagonists (5-HT3 RAs) for The Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: A Review. J. Drug Delivery Ther. [Internet]. 2021 Feb. 15 [cited 2026 Jan. 21];11(1-s):195-9. Available from: https://jddtonline.info/index.php/jddt/article/view/4554